Skip to content

Clinical trials

Completed Pulmonary Embolism trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Embolism Status: Completed Country / region: China Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20023
20062
20074
20091
20121
20142
20173
20182
20191
20201
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer4
Beijing Chao Yang Hospital4
Bristol-Myers Squibb2
Beijing Tsinghua Chang Gung Hospital1
Chinese Pulmonary Vascular Disease Research Group1
Daiichi Sankyo1
Huashan Hospital1
McMaster University1
Morningside (Nantong) Medical Co.,Ltd1
North Sichuan Medical College1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Embolism22
Venous Thrombosis9
Venous Thromboembolism6
Thromboembolism5
Thrombosis4
Asthma1
Bronchiectasis1
Bronchitis1
Embolism1
Esophageal Neoplasms1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.